The price target for Chugai Pharmaceutical (TYO:4519) increases by 7.21% to 5,438.30

The average one-year target price for Chugai Pharmaceutical (TYO:4519) has been revised to 5,438.30 per share. This represents an increase of 7.21% compared to the previous estimate of 5,072.80 from November 26, 2023.

The target price is an average of multiple estimates provided by analysts. The most recent targets range from a minimum of 4,444.00 to a maximum of 6,510.00 per share. The average target price represents an increase of 1.76% from the last reported closing price of 5,344.00 per share.

Chugai Pharmaceutical maintains a dividend yield of 1.50%

At the most recent price, the company's dividend yield is 1.50%.

Moreover, the company's dividend payout ratio is 0.39. This ratio indicates what proportion of a company's earnings is distributed as dividends. A payout ratio of one (1,0) means that 100% of the company's earnings are paid out as dividends. A ratio above one implies that the company is using its savings to maintain its dividend, which is not a healthy situation. It is expected that companies with limited growth prospects will distribute most of their earnings as dividends, which typically translates to a payout ratio between 0.5 and 1.0. On the other hand, companies with good growth prospects are anticipated to retain some of their earnings to invest in those growth opportunities, which is reflected in a payout ratio between zero and 0.5.

The company's 3-year dividend growth rate is 0.60%, demonstrating that it has increased its dividend over time.

What is the sentiment of the funds?

There are institutional investors in Chugai Pharmaceutical. This represents an increase of 4 owners or 1.37% in the last quarter. The average portfolio weight of all funds dedicated to 4519 is 0.35%, an increase of 21.29%. The total number of shares held by institutions increased in the last three months by 6.68% to 107.449 million shares.

What are other shareholders doing?

VGHCX - Vanguard Health Care Fund Investor Shares holds 30.175 million shares, representing a 1.83% stake in the company. No changes in the last quarter.

HLMIX - Harding Loevner International Equity Portfolio Institutional holds 15.393 million shares, representing a 0.94% stake in the company. In its previous statement, the firm reported holding 10.029 million shares, reflecting a 34.85% increase. The firm increased its portfolio allocation by 4519, a 74.42% increase in the last quarter.

VGTSX - Vanguard Total International Stock Index Fund Investor Shares holds 8.703 billion shares, representing a 0.53% stake in the company. In its previous statement, the firm reported holding 8.597 billion shares, representing an increase of 1.21%. The firm increased its portfolio allocation by 4,519, a 10.91% increase in the last quarter.

VTMGX - Vanguard Developed Markets Index Fund Admiral Shares holds 5.219 million shares, representing a 0.32% stake in the company. In its previous statement, the firm reported that it held 5.152 million shares, reflecting an increase of 1.29%. The firm increased its portfolio allocation in 4519 by 14.60% in the last quarter.

PRITX - T. Rowe Price International Stock Fund holds 4.888 billion shares, representing a 0.30% stake in the company. In its previous statement, the firm reported it held 4.994 billion shares, indicating a decrease of 2.19%. The firm increased its portfolio allocation in 4519 by 11.21% in the last quarter.